1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERTEX PHARMACEUTICALS, INC.
Vertex Pharmaceuticals, Inc. XNAS: VRTX

Vertex Pharmaceuticals, Inc. Live Stock Price Today, Share Analysis and Chart

about

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Read More
392.05 2.97 (0.76%)
1.5M
XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Vertex Pharmaceuticals, Inc. is on 03 Sep 2025 for the purpose of 2025 Wells Fargo Healthcare Conference See details
Low Financial Strength
33.3 / 100
Mid Valuation
38.3 / 100
Technically Neutral
36.4 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM

Vertex Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..